Coronavirus News Roundup: Extra Doses Found in Pfizer Vaccine, New Studies on MIS-C

December 25, 2020

Here’s the last roundup of the latest coronavirus-related news in 2020.

Last week, the FDA granted emergency use authorization (EUA) to Moderna’s vaccine candidate for COVID-19 for use in individuals 18 years of age and older.

Read more

Pharmacists Can Use Extra Doses Found in Pfizer COVID-19 Vaccine Vials to Expand Supply

Officials with the FDA have affirmed that pharmacists administering the Pfizer/BioNTech COVID-19 vaccine can use leftover doses in vials containing multiple doses, which may boost the US supply by up to 40%, according to reporting by Politico.

Read more

Fauci: US Still Months Away From COVID-19 Vaccine Approval for Children

Although US health care workers have started receiving the Pfizer-BioNTech COVID-19 vaccine, vaccines for children won’t be available for “months,” according to Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases.

Read more

NIH funds 8 new studies on COVID-19 related MIS-C in children

The National Institutes of Health (NIH) has awarded 8 new research grants to help identify children who are at high risk of contracting multisystem inflammatory syndrome in children (MIS-C), a severe result of COVID-19 in some children.

Read more on Contemporary Pediatrics